Global Automated Sample Storage Market Strategic Research Report
By Type: Automated Biostore Systems, ULT Freezer Systems, Robotic Retrieval Platforms
By Application: Cryogenic Storage Systems, Biobanking Applications, Cell & Gene Therapy
Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America
Overview
The global automated sample storage market occupies a critical position at the intersection of life sciences infrastructure and laboratory automation, encompassing biobanking systems, automated freezer arrays, robotic retrieval platforms, and integrated sample management software. Valued at approximately USD 1.42 billion in 2024, the market has emerged as an indispensable component of pharmaceutical drug discovery pipelines, clinical biobanking networks, and genomics research programs worldwide. As biological sample volumes continue to expand exponentially — driven by precision medicine initiatives, large-scale population genomics cohorts, and accelerating clinical trial activity — the limitations of manual sample handling in terms of sample integrity, traceability, and throughput have become structurally untenable, making automated solutions the default standard of care across leading research institutions and biopharma facilities.
Two primary forces are propelling sustained market expansion through the forecast period. First, the global proliferation of biobank infrastructure — exemplified by initiatives such as the UK Biobank, the NIH All of Us Research Program, and national biobanks across China, Japan, and the European Union — is creating sustained capital demand for high-density, temperature-controlled automated storage systems capable of managing millions of discrete samples with full chain-of-custody documentation. Second, the rapid industrialization of cell and gene therapy manufacturing has elevated sample traceability requirements to a regulatory imperative, compelling therapy developers and CDMOs to invest in purpose-built automated cold-chain storage solutions. A meaningful restraint on market growth is the high capital expenditure associated with enterprise-scale deployment; standalone automated biostore installations frequently exceed USD 2 million, limiting adoption among academic institutions and smaller diagnostic laboratories that operate under constrained procurement budgets.
This report delivers a comprehensive strategic analysis of the global automated sample storage market across the 2025–2032 forecast period, with a base year of 2024. It segments the market by system type, application end-use, and geography — covering six key countries and five regional blocs — while profiling ten leading competitors with detailed assessments of revenue positioning, product strategy, and recent developments. The report is designed specifically for corporate strategy teams evaluating capital allocation in laboratory automation, investment analysts modeling life sciences infrastructure growth, M&A advisors assessing consolidation opportunities, and procurement managers benchmarking vendor capabilities.
Market snapshot
Global Automated Sample Storage Market Strategic Research Report snapshot, 2025–2032
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.Segments covered in this report
Table of contents
01Executive Summary
- 1.1 Market Synopsis
- 1.2 Key Findings
- 1.3 Strategic Recommendations
02Industry Overview & Forecast
- 2.1 Market Definition & Scope
- 2.2 Market Value Forecast, 2025-2032 (Value)
- 2.3 CAGR Analysis & Confidence Intervals
- 2.4 Historical Market Review, 2019-2024
- 2.5 Scenario Analysis (Base, Bull, Bear Cases)
03Market Segmentation by Type
- 3.1 Market by Type Overview
- 3.2 Automated Biostore & High-Density Tube Storage Systems (Value)
- 3.3 Automated Ultra-Low Temperature (ULT) Freezer Systems (Value)
- 3.4 Robotic Sample Retrieval & Handling Platforms (Value)
- 3.5 Cryogenic Automated Storage Systems (Liquid Nitrogen-Based) (Value)
- 3.6 Integrated Sample Management Software & LIMS Modules (Value)
04Market Segmentation by Application
- 4.1 Market by Application Overview
- 4.2 Biobanking & Population Genomics Programs (Value)
- 4.3 Pharmaceutical & Biopharmaceutical Drug Discovery (Value)
- 4.4 Clinical Diagnostics & Hospital Laboratories (Value)
- 4.5 Cell & Gene Therapy Manufacturing (Value)
- 4.6 Contract Research Organizations (CROs) & CDMOs (Value)
05Regional Market Forecast
- 5.1 Regional Revenue Share & CAGR (2024 vs 2032)
- 5.2 North America (Value)
- 5.3 Europe (Value)
- 5.4 Asia Pacific (Value)
- 5.5 Middle East & Africa
- 5.6 Latin America
06Country-Level Market Forecast
- 6.1 Top Countries Overview
- 6.2 United States
- 6.3 United Kingdom
- 6.4 Germany
- 6.5 China
- 6.6 Japan
- 6.7 Canada
07Growth Drivers & Inhibitors
- 7.1 Expansion of National & Commercial Biobank Infrastructure Globally
- 7.2 Regulatory Mandates for Sample Traceability in Cell & Gene Therapy Manufacturing
- 7.3 Rising Throughput Demands from High-Content Genomics & Proteomics Workflows
- 7.4 Market Restraints & Challenges
- 7.5 Opportunities & White-Space Analysis
08Key Company Profiles
- 8.1 Brooks Automation (Azenta Life Sciences) — Revenue, Strategy, Key Products
- 8.2 Hamilton Company — Revenue, Strategy, Key Products
- 8.3 Thermo Fisher Scientific — Revenue, Strategy, Key Products
- 8.4 Beckman Coulter (Danaher) — Revenue, Strategy, Key Products
- 8.5 SCINCO (LICONIC AG) — Revenue, Strategy, Key Products
- 8.6 TTP Labtech — Revenue, Strategy, Key Products
- 8.7 Frost & Sullivan-covered Tec-Lab (BioNordika Group) — Revenue, Strategy, Key Products
- 8.8 Fraunhofer-associated Askion GmbH — Revenue, Strategy, Key Products
- 8.9 Ziath Ltd — Revenue, Strategy, Key Products
- 8.10 Biosero — Revenue, Strategy, Key Products
09Competitive Landscape
- 9.1 Market Concentration & Competitive Intensity
- 9.2 Market Share Analysis (2024)
- 9.3 Competitive Positioning Matrix
- 9.4 Recent Developments: M&A, Partnerships & Product Launches (2023-2025)
10Porter's Five Forces Analysis
- 10.1 Threat of New Entrants
- 10.2 Bargaining Power of Buyers
- 10.3 Bargaining Power of Suppliers
- 10.4 Threat of Substitute Products
- 10.5 Competitive Rivalry Intensity
11PESTLE Analysis
- 11.1 Political Factors
- 11.2 Economic Factors
- 11.3 Social & Demographic Factors
- 11.4 Technological Factors
- 11.5 Legal & Regulatory Factors
- 11.6 Environmental Factors
12SWOT Analysis
- 12.1 Market-Level Strengths
- 12.2 Market-Level Weaknesses
- 12.3 Strategic Opportunities
- 12.4 External Threats
13Future Trends & Outlook
- 13.1 AI-Driven Predictive Sample Inventory Management & Degradation Forecasting
- 13.2 Miniaturization of Cryogenic Automated Storage for Point-of-Care & Decentralized Biobanks
- 13.3 Integration of Blockchain-Based Chain-of-Custody Verification in Sample Tracking Systems
- 13.4 Long-Term Market Outlook (2033-2035)
- 13.5 Investment & M&A Activity Outlook
Frequently asked questions
What is the size of the automated sample storage market?
What is the CAGR of the automated sample storage market?
What is driving growth in the automated sample storage market?
Who are the leading companies in the automated sample storage market?
Which region dominates the automated sample storage market?
What segments are covered in this report?
What is the forecast period covered in this report?
Research Methodology
All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.
Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.
Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.
Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.
CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.
All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.
On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.
Need a customized version?
Get country-, segment- or company-specific intelligence tailored to your exact requirements.
Request custom research →Request a free sample
Receive a sample of Global Automated Sample Storage Market Strategic Research Report before you buy.
Customize This Report
Describe your specific requirements and our analysts will scope and deliver a tailored version.
Request Invoice
We will email a proforma invoice within 24 hours. Report access is granted upon payment confirmation.
Navadhi Market Research · Biotechnology & Life Sciences